According to recent investigations, TMB also influences prognosis in patients whose tumors harbor classical driver mutations, such as EGFR‐mutations.18 For instance, it was found that EGFR‐mutant lung cancers featured lower overall TMB as compared to EGFR‐wild‐type cancers. This evidence concerns the gene EGFR and cancer.